SWX:NESNFood
Assessing Nestlé (SWX:NESN) Valuation After New VOWST Licensing Deal In European Health Science
Nestlé (SWX:NESN) is back in focus after Nestlé Health Science agreed a licensing deal with IdB Holding S.p.A. to develop and commercialize VOWST in Europe, pending approval from the European Medicines Agency.
See our latest analysis for Nestlé.
The VOWST licensing deal lands at a time when Nestlé’s share price, at CHF79.44, has edged higher year to date, but its 1 year total shareholder return is still down, signalling that longer term momentum has been weak even as recent news shifts...